Stephanie P'ng

Haematologist
The Haemophilia and Haemostasis Centre, Fiona Stanley Hospital, Murdoch, Australia
Murdoch, Western Australia, Australia

Presentation(s):

• PB0236 - Evaluation of real-world peri-operative outcomes in patients with haemophilia A (HA) with or without inhibitors on emicizumab prophylaxis in Australia

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0071 - Von Willebrand disease classification- a comparative study of functional assay testing in a tertiary haematology unit

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• OC 32.5 - Interim analysis of the Prospective Cohort Study on Patients with a Haematological Malignancy on Anticoagulants who develop Thrombocytopaenia (HAT Study)

  Monday, June 24, 2024
  10:30 – 10:45 ICT

• PB0565 - Phenotypic characterisation of congenital fibrinogen disorders in Australia

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• OC 50.1 - First interim analysis of clinical outcomes in adults and adolescents with severe hemophilia A receiving efanesoctocog alfa prophylaxis in XTEND-ed, a phase 3 long-term extension study

  Tuesday, June 25, 2024
  09:30 – 09:45 ICT